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Introduction
Protease-activated receptors (PARs) are G protein–coupled re-
ceptors that mediate cellular responses to extracellular prote-
ases (Vu et al., 1991a). Site-specific cleavage of the N-terminal 
ectodomain of these receptors serves to uncover a tethered pep-
tide ligand, which binds to the receptor’s heptahelical bundle to 
effect transmembrane signaling and G protein activation (Vu et 
al., 1991a,b). Among the four PARs found in mammals, PAR1, 
PAR3 and PAR4 mediate cellular responses to the coagulation 
protease thrombin. Genetic studies in mice and pharmacolog-
ical studies in humans suggest that signaling via these recep-
tors helps orchestrate physiological responses to tissue injury 
including hemostasis and perhaps inflammation and repair 
(Coughlin, 2000, 2005). The identity of the physiological acti-
vators of PAR2 and its roles in vivo are less explored.
Studies in cell culture and mice suggest that Par2 together 
with the protease matriptase and its inhibitors Hai1 and Hai2, 
all integral membrane proteins, may make up a local signaling 
system that regulates epithelial behavior (Takeuchi et al., 2000; 
Camerer et al., 2010; Szabo and Bugge, 2011; Sales et al., 
2015b). Matriptase, gene symbol St14, is a type 2 integral mem-
brane protein that displays a trypsin-like serine protease domain 
extracellularly. Subnanomolar concentrations of soluble matrip-
tase protease domain can cleave and activate Par2 in cell culture 
(Takeuchi et al., 2000; Camerer et al., 2010); heterologous coex-
pression of full-length matriptase with Par2 can also promote Par2 
cleavage (Camerer et al., 2010). Par2, matriptase, Hai1, and Hai2 
are naturally coexpressed in most epithelial tissues (Takeuchi et 
al., 2000; Camerer et al., 2010; Szabo and Bugge, 2011; Sales et 
al., 2015b). In the mouse embryo, Par2 is expressed in ectoder-
mal epithelium at the time and place of neural tube closure. Loss 
of Par2 function in certain genetic backgrounds can impair this 
process, as can loss of Hai2 function (Szabo et al., 2009; Camerer 
et al., 2010). Conditional knockout of the matriptase gene in the 
epithelial cells of mouse intestine or skin leads to defective bar-
rier function in these tissues. Intestinal knockout leads to gut 
inflammation and skin knockout to perinatal death from desicca-
tion (List et al., 2002, 2009). Overexpression of matriptase or the 
matriptase activator prostasin in mouse skin leads to hyperplasia, 
inflammation, ichthyosis, and pruritus, and these phenotypes are 
mimicked by Par2 overexpression and prevented by Par2 defi-
ciency (Steinhoff et al., 2003; Frateschi et al., 2011; Sales et al., 
2015a,b). Although matriptase has multiple substrates (Takeuchi 
et al., 2000; Antalis et al., 2011) and Par2 can be activated by 
other trypsin-like proteases (Nystedt et al., 1994; Corvera et al., 
1997; Camerer et al., 2000; Zhao et al., 2014), these and other 
data suggest that matriptase and Par2 may comprise a local sig-
naling system that contributes to the formation and function of 
epithelial tissues (Camerer et al., 2010; Szabo et al., 2014; Le 
Gall et al., 2016; Fig. 1 A). However, the precise cellular behav-
iors regulated by this system and its physiological roles remain 
to be fully illuminated.
Mechanisms that sense and regulate epithelial morphogenesis, integrity, and homeostasis are incompletely understood. 
Protease-activated receptor 2 (Par2), the Par2-activating membrane-tethered protease matriptase, and its inhibitor, he-
patocyte activator inhibitor 1 (Hai1), are coexpressed in most epithelia and may make up a local signaling system that 
regulates epithelial behavior. We explored the role of Par2b in matriptase-dependent skin abnormalities in Hai1a- 
deficient zebrafish embryos. We show an unexpected role for Par2b in regulation of epithelial apical cell extrusion, roles 
in regulating proliferation that were opposite in distinct but adjacent epithelial monolayers, and roles in regulating cell–
cell junctions, mobility, survival, and expression of genes involved in tissue remodeling and inflammation. The epidermal 
growth factor receptor Erbb2 and matrix metalloproteinases, the latter induced by Par2b, may contribute to some 
matriptase- and Par2b-dependent phenotypes and be permissive for others. Our results suggest that local protease- 
activated receptor signaling can coordinate cell behaviors known to contribute to epithelial morphogenesis and 
homeostasis.
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Epithelial growth and remodeling, epithelial-to-mesen-
chymal transformation, and signaling from epithelium to other 
cells play central roles in morphogenesis and organogenesis 
during embryonic development. Epithelial barriers between 
tissues and between an organism and its environment play 
key roles in adult physiology and homeostasis by regulating 
the movement and delivery of molecules between compart-
ments (Marchiando et al., 2010). To support these vital func-
tions, epithelia must regulate cell junctions, polarity, shape, 
size, movement, density, and number and jettison crowded or 
damaged cells—all without losing barrier function (Ragkousi 
and Gibson, 2014; Gudipaty and Rosenblatt, 2017). Given the 
evidence that Par2 activation by matriptase can contribute to 
development and homeostasis of epithelial tissues, we sought a 
system in which the roles of matriptase and Par2 activation in 
an epithelium could be explored in detail.
The zebrafish system offers genetic tractability and ex-
ternal development of large numbers of optically transparent 
embryos amenable to video microscopy. The skin of the early 
zebrafish embryo is a simple bilayer epithelium composed of an 
outer periderm layer and an inner basal layer (Le Guellec et al., 
2004). Periderm keratinocytes adhere tightly to each other and 
form tight junctions to create a strong epithelial barrier (Kiener 
et al., 2008; Kwong and Perry, 2013). Basal layer keratinocytes 
adhere to each other and to the periderm through E-cadherin, 
the extracellular component of the adherens junctions, and 
hemidesmosomes (Slanchev et al., 2009; Sonawane et al., 
2009). Deficiency of the matriptase inhibitor Hai1a (also 
known as Spint1a) in zebrafish embryos causes abnormal skin 
development characterized by accumulation of cell clusters 
on the skin surface, altered cell–cell contacts, leukocyte infil-
tration, and other abnormalities (Carney et al., 2007; Mathias 
et al., 2007). Deficiency of the matriptase homologue St14a 
rescues these phenotypes, suggesting that they are mediated 
by increased matriptase activity associated with loss of its in-
hibition by Hai1a (Carney et al., 2007; Mathias et al., 2007). 
The availability of a matriptase-dependent epithelial phenotype 
in zebrafish embryos provided an opportunity to search for 
and characterize roles of matriptase-driven Par2 signaling in 
a vertebrate epithelium.
Results
Par2b is coexpressed with matriptase and 
Hai1a in the skin of the zebrafish embryo
To determine whether a local matriptase-Hai1-Par2 system 
might operate in zebrafish embryonic epidermis, we first asked 
whether its components are coexpressed in the cell types that 
make up this tissue. We isolated periderm or basal layer cells 
by FACS from embryos collected at 24  h postfertilization 
(hpf) using zebrafish lines carrying a fluorescent marker for 
Figure 1. Zebrafish matriptase cleaves Par2b. (A) Proposed Par2b activation mechanism. Cleavage at R28/M29 unmasks tethered peptide ligand. 
(B) AP-Par2b cleavage reporter. Cleavage releases AP to conditioned medium. (C–E) HEK293 cells were cotransfected with empty pcDNA3.1 or the 
same vector directing expression of the Par2b cleavage reporter AP-Par2b, AP-Par2b carrying a R28A/M29P mutation to ablate the predicted activating 
cleavage site (AP-Par2b csm), or zebrafish matriptase (St14a). AP activity released into the conditioned medium was measured luminometrically. (C) AP 
released by trypsin treatment (4 nM for 10 min) to measure releasable AP. (D) AP released during a 45-min incubation to assess the effect of matriptase 
(St14a) expression. (E) AP activity in detergent extracts of cells expressing AP-Par2b or AP-Par2bmut was measured as an index of total expression of the 
reporter constructs. Data shown are mean ± SEM of three biological replicates, with AP activity expressed as arbitrary luminescence units. This experiment 
was done three times with similar results.
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periderm (Tg (krt4 :nlsEGFP)cy34) or basal layer (TgBAC 
(ΔNp63:Gal4FF)la213;Tg (uas :LifeActGFP)mu271). These lines 
are hereafter called periderm-nuclear-EGFP and basal-layer-
LifeActGFP, respectively. Compared with RNA from whole 
embryos, RNA from the sorted periderm cell preparation was 
enriched ∼17-fold for the periderm markers krt5 and krt4 but 
showed no enrichment for the basal marker p63. RNA from the 
sorted basal layer cell preparation was enriched approximately 
fivefold for p63 but showed no enrichment for krt4 (Table 
S1). Thus, the sorted cell populations showed enrichment 
for the expected markers.
mRNAs encoding the Hai1 zebrafish homologue Hai1a, 
the matriptase homologue St14a, and the Par2 homologue 
Par2b (also known as F2rl1.2) were readily detected in both 
the periderm and basal layer preparations and enriched com-
pared with whole embryo. The level of hai1a, st14a, and par2b 
mRNA in periderm preparations was ∼9-, ∼9-, and ∼16-fold 
enriched, respectively, compared with whole embryo. In basal 
layer, hai1a, st14a, and par2b mRNA were enriched ∼10-, ∼4-, 
and ∼8-fold, respectively (Table S1). These results suggest 
that matriptase gene st14a and the Hai1 gene hai1a are coex-
pressed with par2b in both the periderm and the basal layer 
of zebrafish embryo skin. Previous in situ hybridization studies 
indicated expression of hai1a in the skin of the zebrafish em-
bryo (Carney et al., 2007).
Zebrafish matriptase can cleave zebrafish 
Par2b at its activation site
The Par2b N-terminal exodomain contains the amino acid 
sequence KNGR28/M29. Studies of mammalian matriptase 
substrate specificity (Takeuchi et al., 2000) suggest that matrip-
tase should cleave this sequence at the R28/M29 peptide bond 
(Fig. 1 A). To determine whether zebrafish matriptase can in-
deed cleave zebrafish Par2b like the cognate mammalian pro-
teins, we generated the cleavage reporter AP-Par2b in which 
secreted AP is joined to the N-terminal ectodomain of Par2b. 
Cleavage of AP-Par2b at R28/M29, its predicted activating cleav-
age site, should release AP into the culture medium (Fig. 1 B; 
Ludeman et al., 2004; Camerer et al., 2010). Trypsin efficiently 
cleaves mammalian PAR2 at its activating cleavage site (Nyst-
edt et al., 1994; Camerer et al., 2010). As a positive control, we 
first determined whether AP-Par2b is cleaved by exogenously 
added trypsin. Trypsin treatment of AP-Par2b–expressing 
HEK293 cells released ∼150,000 arbitrary units (AU) AP to 
conditioned medium (Fig. 1 C). No such increase was seen with 
trypsin treatment of untransfected cells or cells expressing an 
AP-Par2b R28A/M29P mutant in which the predicted activating 
cleavage site was ablated (Fig. 1 C). These results suggest that 
trypsin can cleave AP-Par2b at the predicted KNGR28/M29 ac-
tivation site and are consistent with the observation that trypsin 
triggers Par2b internalization (Xu et al., 2011) as well as the 
notion that, like mammalian Par2, zebrafish Par2b can sense 
trypsin-like proteases.
Cells expressing AP-Par2b alone released ∼15,000 AU 
AP during a 45-min sampling period. Coexpression of ze-
brafish matriptase with AP-Par2b was associated with release 
of ∼139,000 AU AP during a 45-min sampling period, a net 
increase of ∼124,000 AU and ninefold that released in the ab-
sence of matriptase expression (Fig.  1  D). Cells expressing 
the cleavage site mutant AP-Par2b R28A/M29P alone released 
∼25,000 AU of AP during the sampling period. Coexpression 
of zebrafish matriptase with the cleavage mutant was associated 
with release of ∼51,000 AU AP, a net increase of ∼26,000 
AU—only twofold that released in the absence of matriptase 
and ∼20% of the increase in AP release seen when wild-type 
AP-Par2b was expressed with matriptase (Fig. 1 D). Total ex-
pression of AP-Par2b and AP-Par2b R28A/M29P was similar in 
these experiments (Fig. 1 E). At face value, these data suggest 
that, during the sampling period, ∼80% of AP release associ-
ated with coexpression of zebrafish matriptase with AP-Par2b 
was caused by AP-Par2b cleavage at the KNGR28/M29 site, with 
∼20% of cleavage occurring at another site. Other potentially 
matriptase-sensitive sites include K25/N26 or R47/E48. Although 
we cannot exclude an indirect action of matriptase (e.g., by 
activating an intermediate protease), these results suggested 
that the zebrafish matriptase can cleave zebrafish Par2b at its 
predicted activating cleavage site and hence serve as a Par2b 
activator. Subsequent genetic experiments described in the fol-
lowing paragraphs are consistent with this notion.
Abnormal skin morphology in hai1a 
morphant embryos is par2b dependent
As noted in the Introduction, loss of function for the matriptase 
inhibitor Hai1a by mutation or morpholino (MO) knockdown 
is associated with matriptase-dependent skin abnormalities 
characterized by clusters of cells on the surface of the skin of 
zebrafish embryos (Carney et al., 2007; Mathias et al., 2007; 
Fig. 2, A, B, and E). The results we have described suggest the 
possibility that matriptase-driven Par2b activity associated with 
removal of matriptase inhibition might contribute to the hai1a 
phenotype. To test this hypothesis, we removed matriptase in-
hibition by using hai1a MOs and replicated key findings with 
hai1a mutants. Mutant hai1a phenotypes were sometimes more 
severe than morphants but were otherwise indistinguishable. 
Conversely, to ensure new findings regarding the role of Par2b 
would not be confounded by off-target effects, we removed 
Par2b activity using a par2b mutant generated with transcrip-
tion activator-like effector nucleases (TAL ENs; see Materials 
and Methods and supplemental data file) and replicated selected 
phenotypes using par2b morphants.
We first examined the effect of matriptase (St14a) or 
Par2b deficiency on the presence of cell clusters on the skin of 
hai1a morphants (Fig. 2, A–E). No skin cell clusters were de-
tected in uninjected wild-type or par2b mutant embryos that did 
not receive hai1a MO. 95% of embryos injected with hai1a MO 
showed clusters, but only 11% of hai1a morphants coinjected 
with st14a MO, 9% of par2b−/− hai1a morphants, and 21% of 
embryos coinjected with hai1a and par2b MOs showed clusters 
(Fig. 2 E). The observation that knockdown of st14a expression 
prevents the appearance of cell clusters in hai1a morphants is 
consistent with prior work and with the model that increased 
matriptase activity contributes to this phenotype (Carney et 
al., 2007; Mathias et al., 2007). The observation that par2b 
mutation or MO knockdown also prevents the appearance of 
cell clusters on the skin of hai1a morphants is consistent with 
the hypothesis that Par2b activation by matriptase contributes 
to the hai1a phenotype.
In addition to cell clusters on the skin surface (Fig. 2 B), 
hai1a mutant and morphant zebrafish embryos have a vari-
ety of abnormalities in basal layer keratinocytes, including 
loss of cell–cell contacts and increased motility and prolifer-
ation (Carney et al., 2007). Periderm has not been studied in 
similar detail in this model. Hai1a-deficient embryos also ex-
hibit increased expression of inflammation markers as well as 
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leukocyte infiltration of tissues (Mathias et al., 2007; LeBert et 
al., 2015). Thus, Hai1a-deficient zebrafish embryos provided an 
opportunity to probe the role of Par2b in a variety of epithelial 
functions in the basal layer and in inflammatory responses and 
to uncover new roles in periderm.
Periderm keratinocytes undergo apical 
extrusion in hai1a morphants in a 
matriptase- and par2b-dependent manner
Toward understanding the nature of the cell clusters in hai1a 
morphants and the effect of Par2b deficiency, we first performed 
time-lapse vital microscopy using a Tg (krt4 :Sce .Abp140 
-Venus)cy22 line, hereafter called periderm-LifeActGFP, which 
expresses a fluorescent marker for filamentous actin (F-actin) 
in periderm keratinocytes. Because abnormal skin morphology 
in hai1a mutants was most frequent and most obvious over the 
ventral yolk sac and at the junction of the yolk sac and trunk 
(Fig. 2 B), this region (Fig. S1) was imaged from 28 to 46 hpf 
in 10 embryos for each condition.
In control periderm-LifeActGFP embryos, little change in 
the arrangement of cells or F-actin distribution was noted over 
the imaging period (Video 1). Strikingly, hai1a morphant peri-
derm-LifeActGFP embryos showed F-actin rings forming and 
contracting around periderm cells that were extruded apically 
from the epithelium. The cells surrounding an extruding cell 
formed rosettes (Fig. 3 A and Videos 2 and 3). Similar events 
occurred in the skin overlying the trunk (Fig. S2). Each extru-
sion event represented a single cell leaving the epithelium, but 
several cells in the same vicinity often underwent extrusion 
(Videos 2, 3, and 5). The formation of an actin ring around a cell 
that is “squeezed” to exit apically from an epithelial monolayer, 
leaving behind a rosette of surrounding cells, is characteristic of 
apical cell extrusion, a process normally used to eject apoptotic, 
damaged, or crowded cells while maintaining epithelial barrier 
function (Gudipaty and Rosenblatt, 2017).
To further explore this extrusion phenotype, we used the 
periderm-nuclear-EGFP line to determine the frequency of ex-
trusion events and visualize nuclear morphology in extruded 
cells as an index of apoptosis (Videos 4, 5, and 6; and Fig. 3 B). 
In control embryos, <0.1% of cells in the field imaged extruded 
during the 28- to 46-hpf imaging period (Video 4 and Fig. 3, C 
and D). The rare cells that did extrude had grossly fragmented 
nuclei (Video 7 and Fig. 3 B), suggesting that extrusion from 
normal periderm reflects jettisoning of the occasional apoptotic 
cell. In periderm of hai1a morphants and mutants, the rate of 
extrusion increased to 4.3% and 4.4%, respectively, but only 
0.1% and 0.4% of cells extruded with obvious nuclear frag-
mentation (Videos 5 and 8 and Fig. 3, C and D). However, the 
extruding cells in hai1a morphants and mutants often showed 
disappearance of nuclear EGFP fluorescence coincident with a 
uniform increase in fluorescence in the cytosol (Videos 5 and 
8), suggesting possible disruption of the nuclear envelope late 
in the extrusion process (see Discussion).
Strikingly, in par2b−/− hai1a morphant embryos, only 
0.3% of cells extruded during imaging (Video 6 and Fig. 3, C 
and D). Similarly, in st14a :hai1a double morphants, only 0.1% 
of cells extruded during the imaging period (Fig. 3, C and D). 
Overall, these results reveal matriptase- and Par2b-dependent 
apical cell extrusion of periderm cells in Hai1a-deficient 
embryos, suggesting that activation of Par2b by matriptase can 
directly or indirectly drive this important epithelial behavior.
Loss of cell–cell contacts, hypermobility, 
and swarming exhibited by basal layer 
keratinocytes in hai1a morphants is 
par2b dependent
Hai1a deficiency promotes basal cell migration (Carney et al., 
2007). Accordingly, we examined the dependence of dynamics 
of such basal layer dynamics on par2b using the basal-layer-
LifeActGFP line. Sequential images and 2-h time-lapse 
videos were acquired on live embryos 24–30 hpf. In control 
embryos, basal layer keratinocytes were stably apposed; 94% 
of cells maintained contact with one or more adjacent cells for 
>60 min (Fig. 4, A and E; and Video 9). In contrast, in hai1a 
morphant embryos, basal layer keratinocytes were usually not 
tightly apposed and extended filopodia and lamellipodia into 
the gaps between cells; only 9% of cells maintained stable 
cell–cell contacts (Fig. 4, B and E; and Video 10). Along with 
decreased cell–cell contact, cell movement was increased in 
hai1a morphants (Videos 10 and 11) compared with controls 
(Video  9), and centripetal movement or “swarming” of basal 
keratinocytes toward aggregations of the same was sometimes 
noted (Video 12). In hai1a :st14a double morphants, the basal 
Figure 2. Par2b deficiency prevents grossly abnormal skin morphology 
in hai1a morphants. (A–D) Wild-type or par2b−/− embryos were injected 
with the indicated MOs and imaged at 30 hpf. Images of control (A), 
hai1a morphant (B), par2b−/−:hai1a morphant (C), and par2b−/− embryos 
(D) are shown. Note the presence of cell clusters on hai1a morphants (B, 
arrowheads) and their absence on controls and Par2b-deficient hai1a mor-
phants. Bar, 200 µm. (E) Percentage of embryos with cell clusters. 100 or 
more embryos were analyzed for each condition; mean ± SEM for three 
independent experiments is shown. Statistical analysis was performed 
using one-way ANO VA and Bonferroni posttest. The hai1a morphant was 
different from all other groups (P < 0.0001).
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layer resembled that of controls; basal keratinocytes were tightly 
apposed and 88% maintained stable cell–cell contacts (Fig. 4, 
D and E; and Video  13). In par2b−/− hai1a morphants, cells 
were more tightly apposed than in hai1a morphants, and 73% 
maintained stable cell–cell contacts compared with 9% in hai1a 
morphants and 94% in controls (Fig. 4, C and E; and Video 14). 
However, moving areas of increased LifeActGFP fluorescence 
suggesting increased F-actin dynamics were sometimes noted 
(Video  14). In the absence of hai1a MO, basal keratinocyte 
behavior in par2b−/− zebrafish was indistinguishable from that 
in wild type (Fig. 4). Collectively, these data show that loss of 
stable cell–cell contacts and hypermobility in hai1a morphants 
is matriptase-dependent and, in large part, par2b-dependent, 
suggesting that activation of Par2b by matriptase directly or 
indirectly helps drive this epithelial-mesenchymal transition-
like behavior of basal layer.
Basal-layer-LifeActGFP embryos provided an op-
portunity to determine whether basal cells extrude in hai1a 
morphant embryos as periderm cells do. In contrast to hai1a 
morphants carrying fluorescent periderm markers, no extrusion 
of fluorescent cells was detected in the time-lapse studies of 
hai1a morphant basal-layer-LifeActGFP embryos described in 
Fig. 4. This observation suggests that apical cell extrusion in 
hai1a morphants was limited to the periderm.
Abnormal distribution of nuclei in periderm 
and basal layer in hai1a morphants is 
par2b dependent
Imaging for the periderm-nuclear-EGFP marker and immuno- 
staining for the basal marker p63 was itself revealing. In contrast 
to the regular spacing of nuclei seen in controls, patches with 
increased numbers of nuclei per unit area were observed in both 
periderm and basal layers in hai1a morphants. These “crowded” 
patches in periderm (Fig.  5  A) were colocated with crowded 
patches in the basal layer (Fig.  5  B), suggesting communica-
tion between layers. The crowded patches seen in still images 
corresponded to the areas of apical extrusion and remodeling of 
the periderm. These areas presumably also corresponded to the 
patches of hypermobility and swarming of basal keratinocytes 
seen with the basal-layer-LifeActGFP line described in Fig.  5 
and Video 12. Crowded patches were not seen in the periderm 
or basal layer of par2b−/− hai1a morphants (Fig. 5 and Fig. S3 
A). The colocation of “crowding” in both layers with extrusion 
in periderm and hypermobility in the basal layer is again consis-
tent with some linkage of these phenomena, and their common 
Par2b dependence suggests that activation of Par2b directly or in-
directly drives remodeling, albeit of distinct types, in both layers.
Abnormal subcellular localization of 
E-cadherin in hai1a morphants is 
par2b dependent
Cell extrusion from the periderm and loss of cell–cell contacts and 
hypermotility in the basal layer suggest that cell–cell junctions 
are altered in both layers in hai1a morphants and mutants. E-cad-
herin distribution in periderm in hai1a morphants has not been 
studied. E-cadherin mislocalization in basal layer keratinocytes 
in hai1a morphants has been reported (Carney et al., 2007), but 
its dependence on par2b is unknown. Accordingly, we examined 
the pattern of E-cadherin immunostaining and its dependence on 
par2b in zebrafish embryos carrying the periderm-nuclear-EGFP 
marker and immunostained for the basal marker p63.
Immunostaining of hai1a morphants for E-cadherin re-
vealed increased granular cytoplasmic staining in the basal layer 
clusters (Fig. 5 C), consistent with redistribution of E-cadherin 
Figure 3. par2b-dependent apical extrusion of epithelial 
cells from periderm in hai1a morphant embryos. (A) The yolk 
sac periderm of a hai1a morphant periderm-LifeActGFP em-
bryo was imaged from 28 to 46 hpf. Three time-lapse panels 
spanning 40 min show an F-actin ring that contracts around 
cells being extruded apically from the periderm. Cells des-
tined to extrude are labeled 1 and 2 in all panels and are 
highlighted with red outline after extrusion has begun. Con-
tracted actin rings remaining at the site of extrusion and at the 
center of rosettes formed by surrounding cells are marked by 
red arrows. Bar, 5 µm. (B) The yolk sac periderm of a con-
trol periderm-nuclear-GFP embryo was imaged from 28 to 46 
hpf. Three panels spanning 18 min show extrusion of a cell 
with an obviously fragmented nucleus (arrow). Bar, 5 µm. (C 
and D) Quantitation of extrusion events in control and hai1a 
morphants with or without Par2b or matriptase (st14a) defi-
ciency. The ventral yolk sac of 10 periderm-nuclear-GFP em-
bryos for each condition was imaged from 28 to 46 hpf, and 
extrusion events were counted and classified by whether the 
nucleus of the extruding cell was not (C) or was (D) obviously 
fragmented. Results are expressed as the number of extrusion 
events as a percentage of the number of cells, usually ∼200, 
present in the field at the start of the imaging period (mean 
± SEM; n = 10). The hai1a morphant and mutant groups in 
C were different from all other groups by one-way ANO VA 
and Bonferroni posttest, P < 0.0001. No groups in D were 
different from control.
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from junctions to intracellular vesicles and in agreement with 
published results (Carney et al., 2007). Importantly, mislocal-
ization of E-cadherin and abnormal clustering of basal layer 
cells was absent in par2b−/− hai1a morphants (Fig. 5). These 
data are in accord with the par2b dependence of loss of stable 
cell–cell contacts and increased cell motility in the basal layer 
of hai1a morphants (Fig. 4 and Videos 9, 10, 11, 12, 13, and 14).
E-cadherin mislocalization was also seen in hai1a morphant 
periderm in areas of clustering of periderm cell nuclei, and such 
mislocalization was largely absent in par2b−/− hai1a morphants 
(Fig. S3 A). Thus, E-cadherin is indeed mislocalized in a manner 
consistent with disruption of adherens junctions in periderm and 
basal layer in hai1a morphants in a par2b-dependent manner.
Opposite effects of Par2b deficiency on 
BrdU incorporation in periderm versus 
basal layer in hai1a morphants
Increased cell proliferation in the basal layer in hai1a mor-
phants has been reported (Carney et al., 2007). Additionally, 
although crowded patches were absent, we noted a relatively 
uniform increase in the overall number of nuclei in periderm of 
par2b−/− hai1a morphants compared with hai1a morphants or 
controls (Fig. 5 A). Accordingly, we characterized cell prolifer-
ation as measured by BrdU incorporation in periderm and basal 
layer of hai1a morphants and its dependence on par2b.
Periderm-nuclear-EGFP embryos were incubated with 
BrdU from 28 to 31 hpf, washed, collected at 46 hpf, and immu-
Figure 4. Loss of cell–cell contacts and increased motility of basal layer keratinocytes in hai1a morphants is par2b dependent. (A–D) The yolk sac basal 
layer of basal-layer-LifeActGFP control or hai1a morphant embryos with or without matriptase or Par2b deficiency was imaged between 24 and 30 hpf. 
Five panels spanning 80 min (m) are shown. (A) Control embryo. Note tightly apposed basal epithelial cells and stable relative positions of numbered cells. 
(B) hai1a morphant embryo. Note loss of cell–cell apposition and changing relative cell positions. (C and D) par2b−/− hai1a morphant (C) and st14a/hai1a 
double morphant (D). Note increased cell apposition and decreased change in position compared with B. Bar, 1 µm. (E) Quantitation of stable cell–cell 
contacts in control and hai1a morphant basal-layer-LifeActGFP embryos with or without St14a or Par2b deficiency. Time-lapse images of a standard field 
over the ventral yolk sac were acquired from 24 to 30 hpf for 10 embryos for each condition, and the percentage of individual cells that maintained contact 
with a neighbor for at least 60 min was determined. Mean ± SEM (n = 10) is shown. Approximately 300 cell–cell contacts were analyzed per condition. 
The hai1a morphant group was different from controls (*, P < 0.0001), but other groups were not, by one-way ANO VA and Bonferroni posttest.
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nostained for BrdU and p63. Colocation of BrdU staining with 
nuclear EGFP was used to identify periderm layer cells that had 
incorporated BrdU; colocation with nuclear p63 staining was 
used to identify basal layer cells (Fig. 6, A and B).
In basal layer, 0.4% of nuclei were BrdU-positive in con-
trols compared with 6.7% in hai1a morphant embryos (Fig. 6, A 
and D). In contrast, the percentage of basal layer nuclei labeled 
with BrdU in hai1a morphant embryos coinjected with st14a 
MO or deficient for Par2b was indistinguishable from control. 
Thus, increased BrdU incorporation in basal layer nuclei in 
hai1a morphants is st14a and par2b dependent, consistent with 
the notion that matriptase-driven Par2b activity contributes to 
proliferation of basal layer cells in this setting.
In periderm, 0.8% of nuclei were BrdU positive in con-
trols compared with 4.0% in hai1a morphants and 0.3% in 
hai1a morphants coinjected with st14a MO (Fig. 6 C). Thus, 
as in the basal layer, loss of Hai1a function was associated with 
a matriptase-dependent increase in the fraction of periderm 
keratinocytes in S-phase. Surprisingly, in contrast to the basal 
layer in which increased BrdU labeling in hai1a morphants 
was prevented by Par2b deficiency, periderm in par2b−/− 
hai1a morphant embryos showed a further increase in BrdU 
labeling, with 11% of nuclei BrdU positive compared with 
4% in hai1a morphants without Par2b deficiency (Fig. 6 C). 
In accord with this result, there was an obvious increase in 
the fraction of periderm cells that underwent nuclear division 
in time-lapse imaging of par2b−/− hai1a morphant embryos 
compared with hai1a morphant without Par2b deficiency or 
controls (Videos 4, 5, and 6).
Of note, BrdU labeling was also increased in periderm in 
par2b−/− embryos compared with controls (5.0% vs. 0.8%), and 
injection of par2b−/− hai1a morphant embryos with an st14a 
MO reduced the percent of periderm nuclei labeled from 11% 
in par2b−/− hai1a morphant embryos to 1.7% (Fig. 6 C). At face 
value, these results suggest that matriptase promotes prolifera-
tion of periderm cells in hai1a morphants in a Par2b-independent 
manner and that Par2b, rather than promoting proliferation as it 
does in the basal layer, inhibits proliferation in periderm.
Leukocyte infiltration of skin and increased 
inflammatory marker expression in hai1a 
morphants is par2b dependent
Leukocyte infiltration of skin and increased expression of 
mmp9 and other inflammatory markers in hai1a morphant 
embryos has been reported (Carney et al., 2007; Mathias et al., 
2007; LeBert et al., 2015). Infiltration of the fin fold with GFP-
positive cells was readily seen in hai1a morphants in the Tg 
(MPO :GFP)uw line, which expresses GFP in neutrophils, and 
such infiltration was absent in par2b :hai1a double morphants 
(Fig. S4). Similarly, expression of mmp9, mmp13, and il1b was 
increased in hai1a morphants, and such increases were st14a 
and par2b dependent (Fig.  7  A). These results suggest that 
matriptase-dependent Par2b activation directly or indirectly 
supports leukocyte infiltration and expression of markers and 
mediators of inflammation in the skin of hai1a morphants.
Matrix metalloproteinase (Mmp)–dependent 
components of the hai1a phenotype
Mmp activity can contribute to tissue remodeling (Page-McCaw 
et al., 2007), and Mmp9 depletion can partially rescue the ap-
pearance of skin clusters in hai1a morphants (LeBert et al., 
2015). This result and our observation that increased Mmp 
expression in hai1a morphants is par2b dependent (Fig. 7 A) 
raised the possibility that Mmp activity might contribute to 
par2b-dependent features of the hai1a phenotype. Accordingly, 
we determined the effect of MO knockdown and pharmacolog-
ical inhibition of Mmp9 and Mmp13 on apical cell extrusion in 
periderm, altered cell–cell contacts in the basal layer, and al-
tered BrdU incorporation in periderm and in basal keratinocytes 
in hai1a morphants (Fig. 7, B–E). Although completely par2b 
dependent (Fig. 3), apical cell extrusion from periderm in hai1a 
morphants was not different in the absence or presence of mmp9 
Figure 5. Altered distribution of nuclei and E-cadherin 
in basal-layer keratinocytes in hai1a morphants and its 
par2b-dependence. Control, hai1a morphant, and par2b−/− 
hai1a morphant periderm-nuclear-GFP embryos were col-
lected at 30 hpf, immunostained for the basal layer marker 
p63 and E-cadherin, and imaged by confocal fluorescence 
microscopy. (A) Nuclear-GFP marker of periderm cells. Note 
regular spacing in controls (left), clustered and crowded ap-
pearance in hai1a morphants (middle), and increased num-
ber in par2b−/− hai1a morphants (right). (B) p63 marker for 
basal layer nuclei. Note regular spacing in controls (left), 
clustered and crowded appearance in hai1a morphants 
(middle), and more control-like pattern in par2b−/− hai1a 
morphants (right). (C) E-cadherin staining in basal layer. Note 
localization to cell–cell junctions in controls (left), aberrant 
distribution with increased cytosolic staining in areas coin-
ciding with clusters of p63-positive nuclei in hai1a morphants 
(middle), and more control-like pattern in par2b−/− hai1a mor-
phants (right). Bar, 20 µm.
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MOs or Mmp9/13 inhibitor (Fig.  7  B). In contrast, exposure 
to Mmp inhibitors partially rescued stable cell–cell contacts in 
the basal layer in hai1a morphants (Fig. 7 C). Most strikingly, 
exposure to Mmp inhibitors mimicked the effects of Par2b defi-
ciency on BrdU incorporation. Specifically, treatment of hai1a 
morphants with Mmp9/13 inhibitor prevented increased BrdU 
incorporation in the basal layer but augmented BrdU incorpora-
tion in periderm (Fig. 7, D and E). Mmp9 MOs had directionally 
similar but smaller effects. At face value, these results suggest 
that Mmp9/13 activity contributes to altered cell–cell inter-
actions and increased BrdU incorporation in the basal layer 
and to restraint of BrdU incorporation in periderm, and given 
par2b-dependent mmp9 and mmp13 expression in hai1a mor-
phants, Par2b-induced Mmp expression may contribute to these 
phenotypes. Our experiments do not exclude the alternative that 
Mmp activity is simply permissive for these phenotypes.
Figure 6. Effect of Par2b deficiency on increased BrdU incorporation associated with loss of hai1a function in the basal layer versus periderm. (A and B) 
Control and hai1a morphants periderm-nuclear-EGFP embryos with and without St14a or Par2b deficiency were incubated with BrdU for 3 h beginning 
at 28 hpf, collected for analysis at 46 hpf, and immunostained for p63 and BrdU. Bar, 50 µm. (B) Colocation of BrdU staining with either nuclear-GFP or 
nuclear p63 staining was used to identify periderm or basal layer cells that had incorporated BrdU, respectively. (C and D) The percentage of BrdU-positive 
nuclei in periderm (C) and basal layer (D) is shown (mean ± SEM of three experiments; for each experiment, 10 embryos were examined per condition, 
and 150–200 cells were analyzed in each embryo). Results were analyzed by one-way ANO VA and Bonferroni posttest. In C, the hai1a/st14a MO group 
and the par2b−/− hai1a/st14a MO groups were not different from control; the hai1a MO group, the par2b−/− group, and the par2b−/− hai1a MO group 
were all different from control, and the par2b−/− and hai1a MO groups were different from the par2b−/− hai1a MO group (*, P < 0.05). In D, the hai1a 
MO group was different from all other groups (*, P < 0.0001).
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Effects of Erbb2 knockdown or EGF 
receptor (EGFR) inhibition on the 
hai1a phenotype
Like Hai1a-deficient embryos (Carney et al., 2007; this study), 
basal layer cells in lgl2 mutant zebrafish embryos show E-cad-
herin redistribution and increased mobility (Reischauer et al., 
2009). These lgl2 phenotypes are prevented by Erbb2 deficiency 
(Reischauer et al., 2009). G protein–coupled receptors including 
Par2 can promote EGFR activation by an incompletely understood 
mechanism dubbed transactivation (Chung et al., 2013; Wang, 
2016). Thus, it is plausible that transactivation of Erbb2 by Par2b 
might contribute to the hai1a phenotype. To explore this hypoth-
esis, we investigated the effect of erbb2 MO and the EGFR inhib-
itor PD168393 on the hai1a phenotype. PD168393 treatment did 
not reduce apical extrusion of cells lacking nuclear fragmentation 
from the periderm in hai1a morphant embryos (Fig. 8 A), nor 
did it reverse E-cadherin redistribution to endosomes in perid-
erm (Fig. S3 B). Unexpectedly, however, PD168393 treatment of 
hai1a morphant embryos was associated with a marked increase 
in apical extrusion of periderm cells with obvious nuclear frag-
mentation (Fig. 8 B). PD168393 treatment did not increase cell 
extrusion in control embryos. The dose of erbb2 MO was lim-
ited by side effects; at the dose used, its effects mimicked those 
of PD168393 treatment directionally but did not reach statistical 
significance. These results suggest that Erbb2 activation does not 
contribute to live apical cell extrusion in Hai1a-deficient embryos 
but that Erbb2 or another PD168393 target may be necessary for 
survival of cells in Hai1a-deficient periderm. Of note, Par2b defi-
ciency blunted the increase in extrusion of cells with fragmented 
nuclei in Hai1a-deficient PD168393-treated embryos, suggesting 
that Par2b signaling may contribute to increased apoptosis and/or 
for extrusion in this setting.
erbb2 MO or PD168393 treatment had no effect on in-
creased BrdU labeling of periderm cells in hai1a morphants, 
but both markedly attenuated the increased BrdU labeling seen 
in the periderm of par2b−/− hai1a morphants (Fig. 8, D and E). 
Indeed, combined Par2b deficiency and Erbb2 inhibition pro-
duced a virtually complete reversal of the hai1a periderm phe-
notype. Collectively, our results are consistent with the notion 
that Erbb2 activity supports survival of periderm cells in hai1a 
morphants with intact par2b function and proliferation of per-
iderm cells in hai1a morphants lacking par2b and extrusion. 
Additionally, the observation that erbb2 MO and PD168393 
blocked proliferation in Hai1a-deficient periderm lacking par2b 
suggests that Erbb2 plays a Par2b-independent role in regulat-
ing proliferation of these cells (Fig. 9 A).
In the basal layer, erbb2 MO and PD168393 treatment 
blunted the increased BrdU labeling in hai1a morphants (Fig. 8, 
F and G). PD168393 treatment also prevented loss of stable 
cell–cell contacts and hypermotility in the basal layer in hai1a 
morphants (Fig.  8  C). Thus, like Par2b, Erbb2 appears to be 
required for increased cell proliferation and altered cell–cell ad-
hesion in the basal layer of hai1a morphants and may mediate 
or be permissive for these behaviors (Fig. 9 B).
Figure 7. Roles of st14a and par2b in mmp9, 
mmp13, and il1b expression and effects of 
Mmp inhibition in hai1a MO embryos. (A) 
Controls, hai1a morphants, and mutant em-
bryos with and without St14a or Par2b defi-
ciency were collected at 30 hpf, and RNA was 
analyzed by quantitative RT-PCR. Expression 
relative to controls is shown (mean ± SEM, 
n = 3). (B) Control and hai1a morphant per-
iderm-nuclear-EGFP embryos with or without 
mmp9 deficiency or mmp9/13 inhibition were 
imaged as in Fig. 3 (B–D). The percentage of 
cells without obvious nuclear fragmentation 
extruding in the field imaged (mean ± SEM; 
n = 10) is shown. Mmp knockdown and inhibi-
tion were without effect on increased extrusion 
in hai1a morphants by one-way ANO VA and 
Bonferroni posttest. NS, not significant. (C–E) 
Control and hai1a morphant basal-layer-Life-
ActGFP embryos with or without Mmp9/13 
inhibition were imaged and analyzed as in 
Fig.  4; mean ± SEM (n = 10 embryos/con-
dition) is shown. Approximately 300 cell–cell 
contacts were analyzed per condition. Two-
way ANO VA and Tukey posttest were used 
to analyze C–E.  In C, the hai1a MO group 
was different from all other groups (*, P < 
0.001). (D and E) Control and hai1a mor-
phants periderm-nuclear-EGFP embryos with 
and without Mmp9 or Mmp9/13 inhibition 
were incubated with BrdU and analyzed as in 
Fig. 5. The percentage of BrdU-positive perid-
erm cells (D) and basal layer cells (E) is shown 
(mean ± SEM; n = 3). In D, the hai1a MO 
groups were different from the control groups 
(*, P < 0.0001), and the Mmp9/13 inhibitor 
hai1a MO group was different from all other 
groups (*, P < 0.0001). In E, the hai1a MO 
without Mmp inhibitor treatment group was dif-
ferent from all other groups (*, P < 0.0001), 
and no other groups differed from control.
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Discussion
Matriptase provides local trypsin-like serine protease activity 
on the surface of epithelial cells (List et al., 2009; Buzza et al., 
2010). Matriptase is negatively regulated by Hai1 and Hai2 
(Oberst et al., 2005; Szabo et al., 2009; Nonboe et al., 2017). 
We and others have provided evidence that matriptase and its 
regulators can modify epithelial cell behavior in part via Par2 
(Bocheva et al., 2009; Camerer et al., 2010; Sales et al., 2015b; 
Le Gall et al., 2016). Gain-of-function for matriptase, its activa-
tors, or Par2 can trigger chronic inflammatory and proliferative 
responses in mouse skin, in some models leading to squamous 
cell carcinoma (Steinhoff et al., 2003; Bocheva et al., 2009; 
Frateschi et al., 2011; Cheng et al., 2014). However, the roles 
of Par2 in regulating epithelial cell behavior and their relation-
ships to matriptase activity have been incompletely explored.
Hai1a-deficient skin in zebrafish embryos has been put for-
ward as a model of chronic inflammation (Mathias et al., 2007). 
It can also be viewed as a model of epithelial remodeling. Using 
this model, we identified and characterized Par2-dependent re-
sponses. Our studies unexpectedly revealed classic epithelial 
apical cell extrusion as a feature of this model and demon-
strated that this behavior is Par2 dependent. Roles for Par2 in 
regulating cell proliferation that were opposite in distinct but 
adjacent epithelial monolayers, and roles in regulating cell–cell 
junctions, mobility, survival, and expression of genes involved 
in tissue remodeling and inflammation, were also uncovered. 
These are epithelial cell behaviors that contribute broadly to 
embryonic development, homeostasis, inflammation and repar-
ative responses, and because Hai1, matriptase, and Par2 are co-
expressed in most mammalian epithelia (Camerer et al., 2010), 
the actions of matriptase-driven Par2 activity in zebrafish skin 
likely have counterparts in other tissues and settings.
Our observations are summarized in Table S2. As pre-
viously reported, the basal layer of Hai1a-deficient embryos 
showed a redistribution of E-cadherin, loss of cell–cell contacts, 
and increased cell motility as well as increased BrdU labeling, 
all of which were matriptase dependent (Carney et al., 2007). 
We show that all of these phenotypes are also Par2b dependent. 
Further, our data suggest that Hai1a, matriptase, and Par2b are 
coexpressed in basal layer cells and that zebrafish matriptase 
can cleave zebrafish Par2b at its activating cleavage site like 
Figure 8. Effect of Erbb2 and EGFR inhi-
bition on the hai1a phenotype. (A and B) 
Control and hai1a morphant periderm-nucle-
ar-EGFP embryos with or without injection of 
erbb2 MO, treatment with the EGFR inhibitor 
PD168393 or par2b deficiency were imaged 
and analyzed as in Fig. 3. Percentage of cells 
undergoing extrusion without (A) and with (B) 
obvious nuclear fragmentation (mean ± SEM; 
n = 10) is shown. In A, the hai1a MO, hai1a 
MO plus PD168393, and hai1a erbb2 MO 
groups were different from control but not 
from each other by one-way ANO VA and 
Bonferroni posttest (*, P ≤ 0.05). No other 
groups were different from control. In B, the 
hai1a MO PD168393 group was different 
from control (*, P < 0.0001). (C–G) Control 
or hai1a morphant basal-layer LifeActGFP 
embryos without or with PD168393 treatment 
were imaged and analyzed as in Fig. 4. Per-
centage of cells in the field imaged that main-
tained stable cell–cell contact (mean ± SEM; 
n = 10) is shown. Two-way ANO VA and Tukey 
posttest were used to analyze C–G. In C, the 
hai1a MO group was different from control 
and from the other groups (*, P < 0.0001). 
Control and hai1a morphant periderm-nuclear- 
EGFP embryos without or with PD168393 
treatment (D and F) or erbb2 MO treatment (E 
and G) were labeled with BrdU and analyzed 
as in Fig. 6. The percentage of cells labeled 
with BrdU (mean ± SEM; n = 3) in periderm 
(D and E) and basal layer (F and G) is shown. 
In D, the hai1a MO and hai1a MO par2b−/− 
groups were different from control and from 
each other (*, P < 0.05). PD168393 treatment 
had a significant effect overall, and the hai1a 
MO par2b−/− ± PD168393 groups were dif-
ferent (*, P < 0.0001). The same result was 
obtained in E with erbb2 MO. In F and G, 
the hai1a group was different from all other 
groups (*, P < 0.05 in F; *, P < 0.0001 in 
G). NS, not significant.
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the cognate mammalian proteins (Camerer et al., 2010). Trans-
plantation experiments by Carney et al. (2007) suggest that 
loss of normal cell–cell contacts and increased movement of 
basal layer cells associated with Hai1a deficiency is basal cell 
autonomous. Par2 is an efficient activator of Rac, and hence of 
F-actin organization in lamellipodia, which drives cell migra-
tion (Camerer et al., 2010; Shi et al., 2013). Par2 activation is 
also associated with loss of E-cadherin adhesion in airway epi-
thelial cells (Winter et al., 2006), and Par2 can promote cell pro-
liferation in some settings (Hirota et al., 2005; Hu et al., 2013; 
Sales et al., 2015b). Thus, a parsimonious model is that loss of 
Hai1a function in basal layer cells leads to increased activity of 
matriptase and Par2b activation in these same cells, with Par2b 
then promoting E-cadherin redistribution, loss of cell–cell con-
tact, motility, and proliferation (Fig.  9). This model does not 
exclude participation of other Hai1a targets or matriptase sub-
strates. For example, matriptase can cleave EpCam in vitro, and 
mutation of epcam in zebrafish triggers cell shedding and pro-
liferative defects (Slanchev et al., 2009; Wu et al., 2017).
Increased il1b, mmp9, and mmp13 expression and leu-
kocyte infiltration of the fin fold in Hai1a-deficient zebraf-
ish embryos were also par2b dependent. Thus, like the basal 
layer responses, this inflammatory response fits a simple 
matriptase-driven Par2b activity–dependent model (Fig.  9). 
Depletion of leukocytes does not prevent the gross skin phe-
notype associated with Hai1a deficiency (Carney et al., 2007; 
Mathias et al., 2007) suggesting that, although leukocyte in-
filtration is downstream of Par2b, it does not cause the other 
Par2-dependent structural and functional abnormalities seen in 
the skin of Hai1a-deficient zebrafish embryos. par2b-dependent 
induction of interleukin-1b (Fig. 7 A) and other cytokines and 
chemokines or par2b-dependent disruption of barrier function 
may trigger leukocyte infiltration. Our results in zebrafish are 
consistent with previous observations suggesting that matrip-
tase and Par2 activity can promote inflammatory responses in 
mouse skin (Frateschi et al., 2011) and suggest that leukocyte 
infiltration may not be causal for proliferative and other skin 
phenotypes in these models.
The periderm of Hai1a-deficient embryos has not been 
previously studied in detail and revealed several distinct and 
surprising behaviors. One was apical cell extrusion that was 
matriptase- and Par2b-dependent. Classically, apical cell ex-
trusion from an epithelium is triggered by apoptosis, dam-
age, or cell crowding (Eisenhoffer et al., 2012; Gudipaty and 
Rosenblatt, 2017). The nuclei of periderm cells extruding in 
Hai1a-deficient embryos were not grossly fragmented. Extrud-
ing cells did show evidence of nuclear envelope breakdown, but 
this occurred late in the extrusion process. Thus, apical cell ex-
trusion in this model is probably not initiated by apoptosis, but 
extruding cells may undergo anoikis.
Interestingly, treatment with Erbb2 inhibitors doubled 
the already high rate of apical extrusion of periderm cells in 
Hai1a-deficient embryos, and this increase was attributable to 
extrusion of cells with already grossly fragmented nuclei. Such 
extrusion was also Parb2 dependent. Thus, our results suggest 
that Par2b activity contributes to apical extrusion of both live 
and apoptotic cells (Fig.  9). Par2b is an efficient activator of 
Rac and F-actin assembly (Shi et al., 2013), and our data are 
consistent with a simple model in which matriptase-driven 
Par2b activity in periderm helps drive cell extrusion directly. 
Par2 is a G protein–coupled receptor (GPCR), and S1pr2, a 
GPCR for sphingosine-1-phosphate, can also stimulate apical 
extrusion in MDCK monolayers and zebrafish epidermis (Gu 
et al., 2011). Thus, different GPCRs may contribute to extru-
sion in different settings.
Figure 9. Summary of effects and working models. Hai1 can inhibit 
matriptase, matriptase can activate Par2, and loss of Hai1a function in 
zebrafish is associated with matriptase-dependent skin phenotypes. We 
characterized the role of Par2b in the two distinct epithelial layers that 
comprise skin, periderm, and basal layer in Hai1a-deficient zebrafish em-
bryos. (A) Par2b is necessary for apical extrusion of apparently live cells 
from the periderm of Hai1a-deficient embryos and for apical extrusion 
of apoptotic cells in such embryos in which the EGFR Erbb2 is inhibited. 
Par2b also negatively regulates periderm cell proliferation. Mmp activity is 
necessary for the latter but not for apical extrusion. Erbb2 is necessary to 
prevent periderm cell apoptosis and associated additional extrusion events 
in Hai1a-deficient embryos and for high levels of cell proliferation in such 
embryos lacking Par2b. Combined deficiency or inhibition of Par2b and 
Erbb2 caused a nearly complete rescue of the Hai1a phenotype. At face 
value, these and other results suggest that matriptase-driven Par2b activ-
ity can drive apical cell extrusion and suppress proliferation in the perid-
erm; that matriptase and Erbb2 promote periderm cell proliferation by a 
Par2b-independent mechanism; and that Erbb2 promotes survival of perid-
erm cells in the setting of Hai1a-deficiency. (B) Par2b is necessary for and 
may drive E-cadherin redistribution, loss of stable cell–cell contacts, and 
increased cell movement and proliferation in the basal layer. These basal 
layer behaviors were partially dependent on Mmps and Erbb2. Thus, these 
molecules may mediate the effects of Par2b activation or play a permis-
sive role. (C) Par2b is necessary for several phenotypes measured at the 
whole-embryo level: appearance of cell clusters on skin, leukocyte infiltra-
tion of the skin, and induction of il1b, mmp9, and mmp13 expression. The 
latter might contribute to phenotypes in A or B. The cell clusters almost cer-
tainly reflect basal cell swarming and areas of increased cell density and 
extrusion in periderm, which tended to be colocated. Collectively, these 
results are consistent with a model in which a local Hai1-matriptase-Par2 
system may mediate responses to altered epithelial integrity.
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Our studies do not exclude participation of other matrip-
tase substrates or less direct mechanisms of Par2b-driven extru-
sion. For example, cell crowding can drive apical cell extrusion 
(Eisenhoffer et al., 2012; Gudipaty and Rosenblatt, 2017), sites 
with an increased rate of extrusion in periderm were colocated 
with crowded patches of periderm cells, and the formation of 
such patches was Par2b dependent. Thus, it is possible that 
Par2b activity first drives periderm remodeling and cell crowd-
ing, with the latter helping to drive extrusion. However, embryos 
deficient in Hai1a and Par2b showed markedly less extrusion 
than Hai1a-deficient embryos despite increased periderm cell 
proliferation and a relatively uniform increase in cell density. 
Thus, crowding, at least as occurs in Hai1a-Par2b-deficient per-
iderm, is not sufficient to drive extrusion.
Areas of apical cell extrusion and increased cell density 
in periderm were also colocated with areas of increased cell 
density in the basal layer, suggesting crosstalk between layers. 
Mmp or Erbb2 inhibition substantially reversed the basal layer 
phenotypes of decreased cell–cell contact and increased mobil-
ity and proliferation in Hai1a-deficient embryos without block-
ing apical cell extrusion or increased proliferation in periderm 
(Table S2). Thus, periderm phenotypes can occur in the absence 
of basal layer phenotypes. Similarly, previous transplantation 
studies suggest that basal layer phenotypes in Hai1a-deficient 
embryos are cell autonomous (Carney et al., 2007) and may 
occur in the absence of periderm phenotypes. Overall, it ap-
pears that matriptase- and Par2b-driven epithelial cell behav-
iors in each layer may be partly autonomous but coordinated by 
cross-talk. Potential mechanisms for cross-talk that promotes 
colocation are discussed later in this article.
In contrast to its effects in the basal layer, Par2b defi-
ciency alone was associated with increased BrdU incorporation 
in periderm. Further, BrdU incorporation in periderm of em-
bryos lacking both Hai1a and Par2b was increased compared 
with embryos lacking either Hai1a or Par2b alone. Interestingly, 
matriptase knockdown largely prevented increased BrdU incor-
poration in this setting. Thus, as in the basal layer, matriptase 
activity promotes proliferation of periderm cells but, unlike in 
the basal layer, Par2b appears to inhibit rather than mediate cell 
proliferation. These results suggest that matriptase promotes 
periderm cell proliferation via a substrates other than Par2b. 
Additionally, opposite roles for Par2b in regulating prolifera-
tion in adjacent epithelial structures raises the possibility that 
this system contributes to a remodeling or differentiation pro-
cess that must coordinate proliferation across cell types.
Although the periderm and basal layers in zebrafish em-
bryo skin represent distinct lineages (Le Guellec et al., 2004) 
and apical layers are derived from the basal layer in mouse 
(Simpson et al., 2011), zebrafish embryo and mouse skin both 
have apical layers comprised of differentiated squamous cells 
and basal layers that are more stem-like. Interestingly, Par2 
overexpression in basal stem cells in mouse skin is associ-
ated with tumorigenesis, but Par2 overexpression in squamous 
cells inhibits proliferation (Rattenholl et al., 2007; Sales et al., 
2015b). Thus, our findings suggest that a functionally analo-
gous system featuring inhibition of apical squamous cell pro-
liferation and stimulation of basal cell proliferation by Par2b is 
conserved across these species and settings.
Mmps contribute to the Hai1a skin phenotype (LeBert et 
al., 2015). We observed that induction of Mmp9 and Mmp13 
expression in Hai1a-deficient embryos is Par2b dependent, 
and that Mmp9 and Mmp13 inhibition mimicked the effects of 
Par2b deficiency in the basal layer. Thus, Par2b-driven increases 
in Mmp9 and Mmp13 expression by basal cells may contribute 
to loss of cell–cell contacts and increased motility and prolifera-
tion of basal layer cells in Hai1a-deficient embryos. Our studies 
do not exclude a less direct mechanism or a permissive role for 
Mmp9 and Mmp13 activity in these phenotypes.
In periderm, Mmp9 and Mmp13 inhibition mimicked the 
effect of Par2b deficiency on BrdU incorporation. Given that 
increased Mmp expression was Par2b dependent, this observa-
tion raises the possibility that Par2b-driven increases in Mmp 
activity may contribute to inhibition of proliferation in perid-
erm. In contrast, and perhaps surprisingly, Mmp9 and Mmp13 
inhibition had no effect on apical cell shedding in Hai1a- 
deficient embryos, suggesting that activity of these proteases is 
unnecessary for this process.
The matriptase- and Par2-driven Erbb2-dependent phe-
notypes we observed in zebrafish skin may have parallels in 
human cancer cells. Par2 activation is associated with Mmp- 
and EGFR-dependent ERK activation and proliferation in a 
colon cancer cell line, and “transactivation” of EGFR by Par2 
has been suggested to contribute to these phenotypes (Darmoul 
et al., 2001, 2004). Par2 has also been reported to promote sur-
vival of an adenocarcinoma-derived lung epithelial cell line by 
transactivation of EGFR (Michel et al., 2014). These results raise 
the possibility that Par2b-dependent activation of Erbb2 might 
contribute to Erbb2-dependent cell proliferation in basal layer 
and cell survival in periderm in Hai1a-deficient zebrafish skin. 
However, the ability of erbb2 MO and PD168393 to reverse the 
increased BrdU incorporation in Hai1a-deficient periderm lack-
ing Par2b suggests that Erbb2 is acting in a Par2b-independent 
manner in this setting, and that Hai1a- and matriptase-depen-
dent, Par2b-independent mechanisms of Erbb2 activation in this 
system remain to be uncovered.
The mechanism by which matriptase activity is regulated 
in normal physiology is not fully understood. In at least some 
polarized epithelial cell types, the matriptase activator prostasin 
traffics to the apical cell membrane, whereas matriptase is ba-
solateral (Buzza et al., 2013). Because these proteases can mu-
tually activate, loss of junctional integrity and polarity resulting 
in altered protease localization might trigger their activation. 
Given that matriptase gain of function leads to E-cadherin redis-
tribution and loss of cell–cell junctions (Buzza et al., 2010) and 
our finding that these activities are Par2b dependent in zebra- 
fish embryo skin, a positive feedback loop might exist in which 
matriptase and Par2b activity begets loss of junctions and polar-
ity with altered trafficking that begets more local matriptase and 
Par2b activity. Further, Hai1a is partially redundant with Hai1b 
in zebrafish skin (Carney et al., 2007). Thus, the matriptase sys-
tem in Hai1a morphant embryos is only partially activated at 
baseline, but it may be more sensitive to activation and ampli-
fication mechanisms. Such a sensitized self-amplifying system 
might allow mechanical or biochemical signals, perhaps induc-
ing cytokines or Mmps or shed matriptase itself to act between 
layers and drive the colocation of patches of affected epithelium 
in basal and periderm layers observed in our studies.
The Par2b-dependent responses that were triggered by 
Hai1a deficiency in our studies—apical cell shedding in the 
periderm; loss of cell–cell contacts, mobility, and proliferation 
in the basal layer; and cytokine and Mmp production—would 
make sense as an initial response to injury, and the notion that 
activation of matriptase and Par2b in this system might nor-
mally be initiated by local injury sensed as loss of epithelial 
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integrity or polarity would fit such a model. The zebrafish skin 
offers a tractable system to test these ideas by future studies to 
determine where and when matriptase and Par2b are activated, 
their cell-autonomous roles in distinct epithelial behaviors, and 
their importance in responses to epithelial perturbations. Use 
of this system to further understand the roles of Par2 may illu-
minate mechanisms contributing to epithelial homeostasis and 
disease and help guide preclinical and clinical studies of drugs 
targeting this receptor (Yau et al., 2013).
Materials and methods
Nomenclature
Matriptase is also known as MTSP1 and St14. The zebrafish matrip-
tase homologue St14a (gene symbol st14a) was studied here. In gen-
eral, we refer to the protein encoded by st14a as matriptase and the 
gene as st14a. Hepatocyte-activator inhibitor 1 (Hai1) is also known as 
Spint1. The zebrafish Hai1 homologue Hai1a, also known as Spint1a 
(gene symbol hai1a or spint1a), was studied here. Par2 is also known 
as F2rl1. The zebrafish Par2 homologue Par2b, also known as F2rl1.2 
(gene symbols par2b or f2rl1.2), was studied here.
par2b and st14a constructs
Zebrafish par2b and zebrafish st14a cDNAs were obtained from GE. 
The Par2b cleavage reporter AP-Par2b was generated in a manner anal-
ogous to previous mammalian versions (Ludeman et al., 2004; Camerer 
et al., 2010). In brief, zebrafish Par2b was amplified by PCR using prim-
ers 5′-GGC CGG ATC CAC CAT GGC GGT GTC CGA GA-3′ and 5′-GGC 
CGC GGC CGC TCA GCA AGT GCT GGT TTC CGT GTT-3′ and inserted 
between the BamH1 and Not1 sites in pcDNA3.1, or using the primers 
5′-GGC CGT TAA CGC CCA GCC AGG CAA AAA TGG-3′ and 5′-GGC 
CGT TAA CGC AAG TGC TGG TTT CCG TGTT-3′ and inserted at the HapI 
site in pCMV-SEAP. A Par2b cleavage site mutant version of AP-Par2b 
was made using the primers 5′-GGC CGG ATC CAC CAT GGC GGT GTC 
CGA GAG CTA CAG GAT TTT ATT ATT TTT GGC GTG TGT CAT TTT TGC 
TTC TGC CCA GCC AGG CAA AAA TG-3′ and 5′-GGC CTC TAG ATC 
AGC AAG TGC TGG TTT CC-3′. The PCR product was used to generate 
a BamHI and XbaI fragment to replace the cognate fragment in AP-Par2b.
Zebrafish st14 was amplified by PCR using primers 5′-GGC 
CGG ATC CAC CAT GGA CCC TAT GGA TGG AGG AAT-3′ and 5′-GGC 
CGC GGC CGC TTA CAC TCC CGT CTT CTC CTT-3′ and subcloned be-
tween the BamHI and NotI sites in pcDNA3.1. Constructs were con-
firmed by sequencing. Enzymes were from New England Biolabs.
AP release assay
HEK 293T cells were plated in DMEM with 10% FBS at a density of 0.5 
× 105 cells/well of a 24-well plate. Approximately 24 h later, cells were 
left untransfected or transfected with empty pcDNA3.1 or pcDNA3.1 con-
structs directing expression of AP-Par2b with a wild-type or mutated cleav-
age site and/or st14a. Approximately 24 h later, wells were washed once 
with 0.5 ml DMEM medium containing 0.1% BSA and 20 mM Hepes, 
and 300 µl medium was added to each well and incubated for 45 min at 
37°C. 200 µl medium was removed and transferred to labeled tubes kept 
on ice. The remaining 100 µl was removed from the wells and cells washed 
once with 0.5 ml medium. 300 µl fresh medium containing 0.1 µg/ml tryp-
sin (TPCK treated; Sigma-Aldrich) was added to each well and incubated 
for 10 min at 37°C. 200 µl of the trypsin-containing medium was removed 
from the wells and kept on ice. The samples from pre- and post-trypsin 
treatments were centrifuged at 13,000 rpm for 10 min, and 60 µl of each 
sample was added to 180 µl of 1× sample dilution buffer from the Tropix 
kit (Applied Biosystems) and heated for 30 min at 65°C. Samples were 
then cooled to room temperature, and 50 µl of each was added to 50 µl 
assay buffer in a 96-well plate in triplicate and incubated for 5 min at room 
temperature. 50 µl reaction buffer containing AP chemiluminescent sub-
strate (Tropix kit) was added to each well and incubated further for 20 min. 
Chemiluminescence was measured in a microplate luminometer (Promega 
Glo Max). Where indicated, total expression of AP-Par2b constructs was 
assessed by lysing cells in 250 µl of 0.2% Triton X-100 24 h after trans-
fection; 15 µl lysate was added to 185 µl Tropix buffer, which was then 
processed as just described to measure AP activity.
Zebrafish maintenance and strains
Zebrafish were maintained and handled in compliance with standard 
(http ://zfin .org) and University of California, San Francisco 
Institutional Animal Care and Use Committee protocols. Wild-type 
strains used were TL, AB, and EKW. The par2b mutant line was 
outcrossed twice to each of these strains and to four of the transgenic 
lines; in all backgrounds, Par2b deficiency rescued the hai1a morphant 
skin phenotype as described in Results. Published transgenic lines 
were Tg (krt4 :nlsEGFP)cy34 (Chen et al., 2011), Tg (krt4 :Sce .Abp140 
-Venus)cy22 (Chen et al., 2011), Tg (UAS :Lifeact -GFP)mu271 (Helker 
et al., 2013), TgBAC (ΔNp63:Gal4FF)la213 (Rasmussen et al., 2015), 
Tg (MPO :GFP)uw (Mathias et al., 2006), and Hai1a Mutant Line: 
spint1lhi2217 (Carney et al., 2007; Mathias et al., 2007).
Injections and MOs
MOs were obtained from Gene Tools. 2 nl of MO solution was in-
jected at the one- to two-cell stage. Sequences and concentrations 
were as follows: Hai1a MO: 5′-ACC CTG AGT AGA GCC AGA GTC 
ATCC-3′, 50 mM (Carney et al., 2007); Par2b (f2rl1.2) MO: 5′-ATT 
CCG CTT TTT CCT CTA GTA CTCC-3′, 100 mM; matriptase1a (st14a) 
MO: 5′-AAC GCA TTC CTC CAT CCA TAG GGTC-3′, 100  mM (Car-
ney et al., 2007); mmp9 MO1 5′-GAA TAA TGT CCC ACC TGT ATG 
TGAC-3′, 50  mM (Volkmann et al., 2010); mmp9 MO2 5′-GTA 
AGT TTA CCT CTG TTA GGG CAGA-3′, 50  mM (Volkmann et al., 
2010); and erbb2 MO: 5′-GTC CGC CTC CAT CGA TTA TTC CTCC-3′, 
50 mM (Lyons et al., 2005).
Generation of par2b (f2rl1.2) mutant
The design of the TAL EN effectors was done with the web tool at https 
://tale -nt .cac .cornell .edu /. TAL EN constructs were assembled using the 
Golden Gate TAL EN and TAL Effector kit 2.0 according to Cermak et 
al. (2011) (Addgene). Two Target sequences were used for exon 2: 5′-
TAC ACC CAG CTG CCATTTA CAT GGG CAA CCTGGC ACT TGC AGA 
CCTG-3′ and 5′-TAT GGC GAG GAG ATG TGC AAAGT ATC AGT GGG 
CTTCTT CTA CGG GAA CAT GTA-3′ (spacer sequence underlined). 
TAL EN effector mRNAs were synthesized using the Ambion mMessage 
mMachine T7 Ultra kit (Applied Biosystems) and injected at the one-cell 
stage. The experiments were done with F2 and subsequent generations.
Drugs
Mmp9 inhibitor I (444278) and Mmp9/13 inhibitor I (444252; Calbio-
chem/Millipore) were used at 100 µM. The EGFR inhibitor PD168393 
(513033; Calbiochem/Millipore) was used at 10 µM. For all the exper-
iments, drugs were added in embryo medium (5.0 mM NaCl, 0.17 mM 
KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4) with 2% DMSO 6 h be-
fore the measurements or time-lapse started and remained present for 
the duration of the experiment.
Live imaging
For photos of live embryos at 30 hpf, the embryos were embedded in 
2% methylcellulose (Sigma-Aldrich) in embryo medium with 0.04% 
tricaine (Sigma-Aldrich). For time-lapse vital microscopy, embryos 
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were embedded in 1% low-melting agar in embryo medium with 0.04% 
tricaine (Sigma-Aldrich). When imaging the periderm, recording started 
at 28 hpf and continued for 18 h, with images acquired at 8-min inter-
vals. A 710 laser-scanning confocal (Zeiss) and spinning disk fluores-
cence (Nikon) microscopes were used. When imaging the basal layer, 
2-h recordings were performed between 24 and 30 hpf with images 
collected at 2-min intervals. A 710 confocal fluorescence microscope 
(Zeiss) was used. Imaging was performed with a long working distance 
20× lens. All the time-lapse studies were performed at 28.5°C. Image 
analysis was performed using Zeiss Black or Fiji ImageJ software.
Immunofluorescence staining and BrdU incorporation
For E-cadherin and p63 staining, embryos were fixed at 30 hpf in 4% 
PFA in PBS overnight and postfixed in methanol at −20°C overnight. 
Staining was performed as previously described (Reischauer et al., 
2009). Mouse E-cadherin antibody (clone 36; 610181; BD Biosci-
ence) was used at 1:100, rabbit p63 antibody (gtx124660; Genetex) 
at 1:100, and secondary antibodies conjugated with Alexa Fluor 564 
and 647 (Life Technologies) at 1:500. For BrdU incorporation and 
staining, embryos at 28 hpf were incubated with 10 mM BrdU (Life 
Technologies) and 2% DMSO in embryo medium for 3 h followed by 
three 5-min washes in embryo medium. Embryos were then incubated 
for 15 h and fixed in PFA 4%. The BrdU staining was performed as 
described (Reischauer et al., 2009). Sheep BrdU antibody (ab1893; 
Abcam) was used at 1:100 and mouse p63 antibody (clone 4A4; sc8431; 
Santa Cruz Biotechnology) at 1:200. Immunostained embryos were 
imaged using a 710 confocal microscope and 20× and 40× long working 
distance lenses. Imaging analysis was performed using Zeiss Black 
or Fiji ImageJ software.
Keratinocyte isolation and quantitative PCR
Periderm and basal layer keratinocytes were sorted from Tg (krt4 
:nlsEGFP)cy34 and TgBAC (ΔNp63:Gal4FF)la213: Tg (UAS :Lifeact 
-GFP)mu271 zebrafish embryos, respectively, as previously described 
(Manoli and Driever, 2012). In brief, 100 embryos of each genotype 
were manually dechorionated at 24 hpf. Cells were dispersed from 
embryos, and GFP-labeled cells were sorted using a FACS Aria2 (BD 
Bioscience) and lysed in Trizol (Sigma-Aldrich); RNA was purified 
using the RNeasy micro-kit (Qiagen) and converted to cDNA library 
using the SuperScript-Vilo kit (Life Technologies). Quantitative 
PCR was performed using TaqMan gene expression master mix 
(Life Technologies) according to the manufacturer’s instructions. 
TaqMan-Fam Probes were ordered from Life Technologies. The 
reaction was performed with 7900HT Fast Real-Time PCR system 
(Applied Biosystems). Probes and assay IDs were as follows: 
reference gene Eef1a1l, assay ID: DR03432748_m1; Il1b, assay 
ID: DR03114367_g1; Mmp2, assay ID: DR03076189; Mmp9, assay 
ID: Dr03139883_g1; Mmp13a, assay ID: Dr03438514_g1; St14a, 
assay ID: AIS09DC; Krt4, assay ID: DR03093320_gh; P63, assay 
ID: Dr03131730_m1; Spint1a, assay ID: DR03139912_m1; and 
F2rl1.2, assay ID: Dr03168088.
Statistical analysis
One-way ANO VA with Bonferroni posttest or two-way ANO VA with 
Tukey posttest were used to identify significant differences between 
treatment groups. Sample sizes and p-values are indicated in figure 
legends. Asterisk in figures indicates significant differences after cor-
rection for multiple comparisons with p-value indicated in the legends. 
Calculations were done using Prism statistical software (GraphPad), 
and the level of statistical significance was set at P < 0.05 for initial 
ANO VA before any post-tests were permitted.
Online supplemental material
Fig. S1 shows photos of a mounted zebrafish embryo indicating the 
region selected for time-lapse imaging. Fig. S2 shows apical extru-
sion of cells from the trunk periderm cells in hai1a morphants. Fig. 
S3 shows distribution of nuclei and subcellular distribution of E-cad-
herin in periderm in control and hai1a morphants and effect of inhibi-
tion of mmp9/mmp13 (by drugs and MOs), erbb2 (by MO), and EGFR 
(by inhibitor PD168393). Fig. S4 shows leukocyte infiltration of skin 
in hai1a morphant and rescue by Par2b depletion. Video 1 show per-
iderm in control with LifeAct-GFP marker. Video 2 shows periderm 
in hai1a morphant showing cell extrusion with LifeAct-GFP marker. 
Video  3 shows periderm in hai1a morphant showing multiple sin-
gle cell extrusions from one site with LifeAct-GFP marker. Video 4 
shows periderm in control using nuclear-GFP marker. Video 5 shows 
periderm in hai1a morphant showing clustering of extrusion events in 
an area of apparent cell crowding with nuclear-GFP marker. Video 6 
shows periderm in par2b mutant/hai1a morphant showing increased 
nuclear division with nuclear-GFP marker. Video  7 shows rare ex-
trusion of a periderm keratinocyte with nuclear fragmentation in a 
control embryo with nuclear-GFP marker. Video 8 shows a common 
event in hai1a morphants—extrusion of cells with an initially intact 
nucleus that appears to undergo nuclear envelope breakdown late 
in the process (with nuclear-GFP marker). Video 9 shows the basal 
layer in control showing stable cell–cell contact with LifeAct-GFP 
marker. Videos 10 and 11 show the basal layer in hai1a morphants 
showing lack of stable cell–cell interaction, filopodia and lamelli-
podia formation, and increased cell movement. with LifeAct-GFP 
marker Video 12 shows the basal layer in hai1a morphant showing 
swarming behavior with LifeAct-GFP marker. Video 13 shows basal 
layer in st14a/hai1a morphants showing restoration of stable cell–cell 
contact with LifeAct-GFP marker. Video 14 shows the basal layer in 
par2a mutant/hai1a morphant showing restoration of stable cell–cell 
contacts with LifeAct-GFP marker. Table S1 shows quantitative PCR 
data showing expression of mRNA for hai1a, st14a, and par2b in 
periderm and basal layer keratinocytes sorted from 24-hpf zebrafish 
embryos. keratin4 and tp63 are included as periderm and basal ke-
ratinocyte markers. Table S2 is a summary of effects of Par2b and 
St14a deficiency on Hai1a phenotypes. The supplemental data file 
shows nucleotide and predicted amino acid sequences of wild-type 
and TAL EN mutant zebrafish par2b.
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